Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03170206

Recruitment Status : Active, not recruiting

First Posted : May 30, 2017

Last Update Posted : March 18, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

Pfizer

Array BioPharma

Information provided by (Responsible Party):

Geoffrey Shapiro, MD, PhD, Dana-Farber Cancer Institute

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	February 28, 2023
Estimated Study Completion Date :	June 30, 2025

To Top